Skip to main content
. 2019 May 17;24(10):1896. doi: 10.3390/molecules24101896

Figure 3.

Figure 3

Results of FlowSight analysis of HL60 cells treated with t-resveratrol in IC50 (Columns: BF—BrightField, AnxV—Annexin V-FITC, PI—Propidium Iodide; AnxV/PI—Coexpression of Annexin V-FITC and Propidium Iodide; PhiPhiLux—Caspase3-FITC; PhiPhiLux/PI—coexpression of Caspase3-FITC and propidium iodide; Rows: A—viable cells (AnxV-/PI-); B—Early-apoptic cells (AnxV+/PI-); C—Late-apoptic cells (AnxV+/PI+); D—Necrotic cells (AnxV-/PI+); E—viable cells (Casp-/PI-); F— apoptic cells (Casp+/PI-, Casp+/PI+); G—necrotic cells (Casp-/PI+)).